Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic conditions ...
Discover why Regeneron Pharmaceuticals, Inc.'s Q3 earnings impress, fueled by Dupixent growth and a robust pipeline. Click ...
Regeneron Pharmaceuticals beat Wall Street estimates for third-quarter results on Tuesday, helped by strong demand for its ...
Apogee Therapeutics, Inc. targets atopic dermatitis with APG777, aiming to outperform Dupixent. Learn more about APGE stock ...
TIME and Statista have named 500 companies doing best for the Earth Methodology: How TIME and Statista Determined the World's Most Sustainable Companies of 2025 In the fight against climate change, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback